Unexplained weight loss (UWL), defined as a loss of 5% of total body weight within a six-month period without a known cause, poses a diagnostic challenge in clinical practice. It can indicate underlying serious illnesses, and thus, necessitates a thorough evaluation.
The initial assessment for UWL should include a detailed history and physical examination. The history should focus on dietary intake, physical activity, psychiatric status, and associated symptoms. The physical examination should be comprehensive, including a thorough examination of the gastrointestinal system, lymph nodes, and thyroid gland.
A stepwise diagnostic approach is recommended for UWL. Initial laboratory tests should include a complete blood count, metabolic panel, thyroid function tests, and urinalysis. If these tests are inconclusive, further investigations such as imaging studies or endoscopies may be warranted. The choice of further tests should be guided by the patient's history and physical examination findings.
Imaging studies play a crucial role in the evaluation of UWL. Computed tomography (CT) of the abdomen and pelvis can identify malignancies, while positron emission tomography (PET) can detect metabolically active diseases. However, these should only be pursued if initial tests are inconclusive and the patient has suggestive symptoms.
Management of UWL depends on the underlying cause. For patients with malignancies or chronic infections, appropriate treatment should be initiated promptly. For patients with psychiatric disorders or malnutrition, a multidisciplinary approach involving psychiatrists and dietitians may be beneficial.
Evaluating unexplained weight loss requires a systematic approach, starting with a thorough history and physical examination, followed by a stepwise diagnostic process. This comprehensive approach can help clinicians identify serious underlying conditions and initiate appropriate management.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation